Tuesday’s packed schedule will let attendees hear from Anders Tveteraas, international head of patient solutions and services at Novartis and Julie Anderson, principal, behavioural health s
From Akili’s transition to over-the-counter to the downfall of Pear Therapeutics, it’s been an exciting time lately in the world of digital therapeutics.
From artificial intelligence and digital therapeutics to the latest in oncological research and RNA therapeutics, from developments in the CNS field to what’s what in customer experience an
One of the pioneers of the prescription digital therapeutics (DTx) sector, Akili Interactive, has decided to abandon that approach and focus exclusively on a direct-to-con